Tag: Pegfilgrastim Biosimilar
USFDA accepts application from Lupin for Pegfilgrastim Biosimilar
Lupin announced that the USFDA has accepted the Biologics License Application (BLA) for its proposed biosimilar to Neulasta (pegfilgrastim) through a filing...
Latest posts
Govt releases draft policy for R&D, Pharma and Medical Devices
The Department of Pharmaceuticals (DoP) has come out with a draft policy to catalyse research and development (R&D) and innovation in pharmaceutical...
Authors
